We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Resection Electrodes Aid Urologic Surgery

By HospiMedica staff writers
Posted on 30 Apr 2007
A new line of resection electrodes for urologic procedures will enable urologists to improve prostate health.

The Cook resection electrodes are intended for urologic procedures such as transurethral resection of the prostate (TURP) and transurethral resection of bladder tumors (TURBT), with minimal bleeding, increased visibility, and decreased procedure time. More...
Five different types of electrodes, compatible with all major brands of resectoscopes, are offered.

The resection electrode types include: a hand-crafted, temperature-resistant tungsten wire-cutting loop; a coagulating perforated resector that provides a 40% greater coagulation zone than standard cutting loops and performs cutting and coagulation simultaneously during tissue resection; a dimpled vaporization roller that offers a smoother area of vaporization than a grooved roller while providing deep-tissue coagulation; a roller ball and roller barrel, which are used for coagulation and ablation of soft tissue in the bladder and prostate (the roller ball may also be used for endometrial ablation in the uterus); and a Collings knife that allows urologists access to all areas of the prostate and is most commonly used for ureteral meatotomy and transurethral incision of the prostate (TUIP). The resection electrodes are made by Cook Medical (Bloomington, IN, USA).

"The Cook resection electrodes are a specially crafted set of instruments designed with a patient's comfort and the urologist's medical challenges in mind, enabling a safe and quick procedure,” said Jerry French, senior vice president and global strategic business unit leader for Cook Medical's urology division.

TURP is the gold standard treatment for benign prostatic hyperplasia (BPH), also known as an enlarged prostate, which affects 50% of men aged 51-60 and 90% of men past age 80. TURBT is the most common procedure for treating bladder tumors, which account for 90% of urinary tract cancers.


Related Links:
Cook Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.